AXSM financials
Axsome Therapeutics (AXSM) financials: revenue, profit and margins by year and quarter, the balance sheet and cash flow.
AXSM income statement, yearly
| Year | Revenue | Gross profit | Operating income | Net income | EPS |
|---|---|---|---|---|---|
| 2025 | $638.50M | $591.02M | -$169.24M | -$183.17M | -3.68 |
| 2024 | $385.69M | $352.39M | -$280.56M | -$287.22M | -5.99 |
| 2023 | $270.60M | $244.53M | -$231.82M | -$239.24M | -5.27 |
| 2022 | $50.04M | $44.84M | -$179.80M | -$187.13M | -4.60 |
| 2021 | $0.00 | $0.00 | -$124.71M | -$130.40M | -3.47 |
| 2020 | $0.00 | $0.00 | -$99.14M | -$102.90M | -2.83 |
- AXSM revenue was $638.50M in fiscal 2025, net income -$183.17M.
Updated 2026-11-02 18:28 UTC